Pitcairn Company »

Olema Pharmaceuticals shares owned by Pitcairn Company

Quarter-by-quarter ownership of Olema Pharmaceuticals (OLMA) shares owned by Pitcairn Company from 13F filings

Historical chart of Pitcairn Company investment in Olema Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Olema Pharmaceuticals held by Pitcairn Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Olema Pharmaceuticals by Pitcairn Company

Quarter filed Position value Share count Share price at filing
2024-09-30 $293k 25k 11.94

More positions owned by Pitcairn Company

Ishares Tr Russell 3000 Etf (IWV)
Direxion Shs Etf Tr Auspce Cmd Stg (COM)
New York Life Investments Et Nyli Hedge Multi (QAI)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Vaneck Merk Gold Etf Gold Shs (OUNZ)
Apple (AAPL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Spdr Index Shs Fds Msci Acwi Exus (CWI)
Berkshire Hathaway Inc Del Cl A (BRK.A)
Amazon (AMZN)
Ishares Tr Rus 1000 Etf (IWB)
Johnson & Johnson (JNJ)
Procter & Gamble Company (PG)
Broadcom (AVGO)

View all positions for Pitcairn Company

Top funds holding Olema Pharmaceuticals

BVF
Paradigm Biocapital Advisors
Deep Track Capital
BlackRock
BlackRock
Point72 Asset Management
Logos Global Management
Vanguard Group
MPM Oncology Impact Management
State Street Corporation
Pictet Asset Management Holding SA
Dimensional Fund Advisors
Woodline Partners
Citadel Advisors
Candriam Luxembourg S.C.A.

View all funds holding Olema Pharmaceuticals